Shareholder Update Q3 2018
October 02, 2018 00:00 ET | Factor Therapeutics
Highlights: Venous leg ulcer Phase 2 trial on track:  top-line results mid-NovemberDiabetic foot ulcer pilot clinical study: in development with key US researchersOcular wounds: international patent...